Small-cap stock under ₹25 jumps 5% after THIS update on rights issue
Infibeam Avenues share price jumped over 5% on Monday after the company shared an update regarding its rights issue. Infibeam Avenues shares rallied as much as 5.13% to ₹ 22.95 apiece on the BSE.
Infibeam Avenues said its Rights Issue Committee will meet on 19 June 2025 to consider and approve various terms of the rights issue. It will discuss and finalise rights issue record date, price, entitlement ratio and other terms.
'... the meeting of the Rights Issue Committee is scheduled to be held on Thursday, June 19, 2025 inter alia to consider discuss and approve various terms and conditions of the Rights Issue including determination of the Rights Issue price, Record Date and Rights Entitlement ratio and other matters incidental or connected therewith and to consider other business items, if any,' Infibeam Avenues said in a regulatory filing on June 16.
Earlier on June 09, Infibeam Avenues said its Rights Issue Committee at its meeting considered and approved the Draft Letter of Offer in relation to the Rights Issue of the company to be filed with BSE and National Stock Exchange of India (NSE) for their in-principle approvals.
The board of directors of Infibeam Avenues on May 9 had approved raising of funds through issue of equity shares having face value of Re 1 for an aggregate amount of ₹ 700 crores on Rights Issue.
Infibeam Avenues share price has gained 20% in one month, and rallied 26% in three months. However, the small-cap stock has fallen 13% on a year-to-date (YTD) basis, and has dropped 27% in one year. Infibeam Avenues shares have delivered strong returns over the long term, as the stock has jumped 55% in two years and 85% in five years.
At 3:05 PM, Infibeam Avenues share price was trading 3.53% higher at ₹ 22.60 apiece on the BSE.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
an hour ago
- Economic Times
Can equities sustain their rebound amidst ongoing Middle East conflict?
Agencies Live Events (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel Mumbai: Indian equities rebounded on Monday after two straight days of losses, mirroring gains in other Asian markets, which shrugged off worries about the ongoing Iran-Israel conflict and higher oil Nifty rose 227.9 points, or 0.9%, to close at 24,946. BSE's Sensex rose 677.5 points, or 0.8%, to end at 81,796. Both indices fell 1.7% in the previous two trading sessions after tensions in the Middle East escalated after Israel had launched unprecedented strikes on Iran, sending global oil prices in Asia, Japan was up 1.3%, China advanced 0.35%, Hong Kong rose 0.7%, and South Korea gained 1.8%. Taiwan dropped 0.1%."Global markets have brushed aside their concerns about the Iran-Israel conflict for now because the US is expected to step in in the next couple of days and help negotiate through the conflict," said Aamar Deo Singh, senior vice president of research, Angel One. "India is not very heavily dependent on Iran for its crude oil imports, and Brent crude prices also came off on Monday, which is providing more comfort to traders."Brent Crude August futures declined 1.2% to $73.3 per barrel on Monday evening after hitting as much as $76 earlier in the Volatility Index or VIX-the market's fear gauge-fell by 1.6% to 14.8 levels on Monday, indicating easing risk sentiment."With Iran showing limited capacity to escalate the conflict further, the situation has become more one-sided, and some degree of de-escalation is now expected, which has brought a sense of optimism back to the street," said Pranay Aggarwal, director and CEO of Nifty Midcap 150 gained 0.75% and the Nifty Small-cap 250 rose 0.5% at close.
Time of India
2 hours ago
- Time of India
Can equities sustain their rebound amidst ongoing Middle East conflict?
Mumbai: Indian equities rebounded on Monday after two straight days of losses, mirroring gains in other Asian markets, which shrugged off worries about the ongoing Iran-Israel conflict and higher oil prices. NSE's Nifty rose 227.9 points, or 0.9%, to close at 24,946. BSE's Sensex rose 677.5 points, or 0.8%, to end at 81,796. Both indices fell 1.7% in the previous two trading sessions after tensions in the Middle East escalated after Israel had launched unprecedented strikes on Iran, sending global oil prices soaring. Elsewhere in Asia, Japan was up 1.3%, China advanced 0.35%, Hong Kong rose 0.7%, and South Korea gained 1.8%. Taiwan dropped 0.1%. Agencies "Global markets have brushed aside their concerns about the Iran-Israel conflict for now because the US is expected to step in in the next couple of days and help negotiate through the conflict," said Aamar Deo Singh, senior vice president of research, Angel One. "India is not very heavily dependent on Iran for its crude oil imports, and Brent crude prices also came off on Monday, which is providing more comfort to traders." Brent Crude August futures declined 1.2% to $73.3 per barrel on Monday evening after hitting as much as $76 earlier in the day. Live Events The Volatility Index or VIX-the market's fear gauge-fell by 1.6% to 14.8 levels on Monday, indicating easing risk sentiment. "With Iran showing limited capacity to escalate the conflict further, the situation has become more one-sided, and some degree of de-escalation is now expected, which has brought a sense of optimism back to the street," said Pranay Aggarwal, director and CEO of Stoxkart. The Nifty Midcap 150 gained 0.75% and the Nifty Small-cap 250 rose 0.5% at close.
Mint
6 hours ago
- Mint
Biocon shares in focus after board opens up QIP fundraising on 16 June, sets floor price at ₹340.20/share
Biocon shares will be in focus of stock market investors after the company's board of directors announce the opening of the QIP (Qualified Institutional Placement) fundraising on 16 June 2025, according to an exchange filing. 'The Fund Raising Committee has at its meeting held today, i.e. Monday, June 16, 2025, authorizing the opening of the issue,' said Biocon in the BSE filing. The pharma company also approved the floor price of the QIP issue to be at ₹ 340.20 per equity share. Biocon disclosed that the company has the ability to discount the offer further to not more than 5 per cent on the floor price of the QIP issue. 'The company may, at its discretion, offer a discount of not more than 5% on the floor price for the issue,' said Biocon in the exchange filing. The firm will decide the issue price after consultation with the book-running lead managers appointed in relation to the case. Biocon shares closed 0.52 per cent higher at ₹ 357.30 after Monday's stock market session, compared to ₹ 355.45 at the previous stock market close. The company announced the outcome of its board meeting after the market operating hours on 16 June 2025. Shares of the pharmaceutical company have given investors more than 637.35 per cent since its listing in the Indian stock market in 2004. However, the shares lost 6.37 per cent in the last five years. In the last one-year period, the stock has gained 8.71 per cent, and is trading 4.31 per cent higher in the last five stock market sessions. Biocon shares hit their 52-week high level at ₹ 404.60 on 21 January 2025, and the 52-week low level was at ₹ 290.80 on 3 March 2025, according to data collected from the BSE website. The pharma company's market capitalisation (M-Cap) was at ₹ 42,897.44 crore as of the stock market close on Monday, 16 June 2025.
